Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/30421
Title: Integration and application of clinical practice guidelines for the diagnosis of idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis.
Austin Authors: Marinescu, Daniel-Costin;Raghu, Ganesh;Remy-Jardin, Martine;Travis, William D;Adegunsoye, Ayodeji;Beasley, Mary Beth;Chung, Jonathan H;Churg, Andrew;Cottin, Vincent;Egashira, Ryoko;Fernández Pérez, Evans R;Inoue, Yoshikazu;Johannson, Kerri A;Kazerooni, Ella A;Khor, Yet H ;Lynch, David A;Müller, Nestor L;Myers, Jeffrey L;Nicholson, Andrew G;Rajan, Sujeet;Saito-Koyama, Ryoko;Troy, Lauren;Walsh, Simon L F;Wells, Athol U;Wijsenbeek, Marlies S;Wright, Joanne L;Ryerson, Christopher J
Affiliation: Respiratory and Sleep Medicine
Department of Medicine, University of British Columbia, Vancouver, BC, Canada..
Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, NSW, Australia..
Respiratory Research@Alfred, Central Clinical School, Monash University, Melbourne, Victoria, Australia..
Center for Interstitial Lung Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA..
Department of Thoracic Imaging, Institut Coeur Poumon, Boulevard Jules Leclercq, Lille, France..
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA..
Section of Pulmonary and Critical Care, Department of Medicine, University of Chicago, IL, USA..
Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA..
Department of Radiology, University of Chicago, IL, USA..
Department of Pathology, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada..
National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon, Lyon, France..
Department of Radiology, Faculty of Medicine, Saga University, Saga, Japan..
Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, CO, USA..
Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan..
Department of Medicine, University of Calgary, Calgary, AB, Canada..
Departments of Radiology & Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA..
Department of Radiology, National Jewish Health, Denver, CO, USA..
Department of Radiology, University of British Columbia, Vancouver, BC, Canada..
Department of Pathology, University of Michigan, Ann Arbor, MI, USA..
Department of Histopathology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, UK..
Department of Chest Medicine, Bombay Hospital Institute of Medical Sciences, Bhatia Hospital, Mumbai, India..
Department of Pathology, Tohoku University Graduate School of Medicine, Miyagi, Japan..
National Heart and Lung Institute, Imperial College, London, UK..
Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK..
Center of Excellence for Interstitial Lung Diseases and Sarcoidosis, Department of Respiratory Medicine, Erasmus University Medical Center, Rotterdam, Netherlands..
Department of Pathology, St. Paul's Hospital and University of British Columbia, Vancouver, BC, Canada..
Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada..
Issue Date: 20-Jun-2022
Date: 2022
Publication information: Chest 2022; 162(3): 614-629
Abstract: Recent clinical practice guidelines have addressed the diagnosis of idiopathic pulmonary fibrosis (IPF) and fibrotic hypersensitivity pneumonitis (fHP). These disease-specific guidelines were developed independently, without clear direction on how to concurrently apply their respective recommendations within a single patient, where discrimination between these two fibrotic interstitial lung diseases represents a frequent diagnostic challenge. The objective of this document, created by an international group of experts, was to suggest a pragmatic approach on how to apply existing guidelines to distinguish IPF and fHP. Key clinical, radiological, and pathological features described in previous guidelines are integrated in a set of diagnostic algorithms, which are then placed in the broader context of multidisciplinary discussion to guide the generation of a consensus diagnosis. While these algorithms necessarily reflect some uncertainty wherever strong evidence is lacking, they provide insight into the current approach favored by experts in the field based on currently available knowledge. The authors further identify priorities for future research to clarify ongoing uncertainties in the diagnosis of fibrotic interstitial lung diseases.
URI: https://ahro.austin.org.au/austinjspui/handle/1/30421
DOI: 10.1016/j.chest.2022.06.013
ORCID: 0000-0002-5434-9342
Journal: Chest
PubMed URL: 35738345
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/35738345/
Type: Journal Article
Subjects: clinical practice guidelines
hypersensitivity pneumonitis
idiopathic pulmonary fibrosis
multidisciplinary discussion
usual interstitial pneumonia
Appears in Collections:Journal articles

Show full item record

Page view(s)

28
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.